Maravai Lifesciences Holdings (MRVI) Interest & Investment Income (2022 - 2026)

Maravai Lifesciences Holdings' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 41.92% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $10.1 million (down 56.94% YoY), while the FY2025 annual figure was $11.4 million, down 58.27% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $1.9 million, down from $2.4 million in the prior quarter.
• The five-year high for Interest & Investment Income was $7.5 million in Q4 2023, with the low at $1.9 million in Q1 2026.
• The 5-year median for Interest & Investment Income is $6.0 million (2023), against an average of $5.1 million.
• The sharpest annual moves came in 2023 and 2025: Interest & Investment Income jumped 219.03% in 2023, then plunged 60.5% in 2025.
• Maravai Lifesciences Holdings' Interest & Investment Income stood at $2.3 million in 2022, then surged by 219.03% to $7.5 million in 2023, then declined by 19.08% to $6.0 million in 2024, then tumbled by 60.5% to $2.4 million in 2025, then declined by 21.43% to $1.9 million in 2026.
• Business Quant data shows MRVI's Interest & Investment Income at $1.9 million in Q1 2026, $2.4 million in Q4 2025, and $2.8 million in Q3 2025.